Calgary, Alberta--(Newsfile Corp. - July 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (" Hemostemix " or the " Company ") announces that the TSX Venture Exchange (" TSXV ") conditionally approved the Company's previously disclosed non-brokered private placement (the " Offering ") in the amount of CAD $469,366. The Offering consisted of the issuance of 3,911,385 Common Shares at a price of CAD $0.12. As... Read More